Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 2812-2817

  Mahony, James B ^a,b   Blackhouse, Gord ^a   Babwah, Jesse ^b   Smieja, Marek ^a,b   Buracond, Sonya ^b   Chong, Sylvia ^b   Ciccotelli, William ^a,b   O'Shea, Tim ^a,b   Alnakhli, Daifallah ^a,b   Griffiths Turner, May ^b   Goeree, Ron ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CHILD; COST BENEFIT ANALYSIS; DECISION TREE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FLUORESCENT ANTIBODY TECHNIQUE; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS CULTURE; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION;

COSTS AND COST ANALYSIS; HUMANS; MICROSCOPY, FLUORESCENCE; ONTARIO; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; VIRUS CULTIVATION; VIRUS DISEASES; VIRUSES;

SPRING VIREMIA OF CARP VIRUS;

EID: 69949104609     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00556-09     Document Type: Article

References (17)

1. Barenfanger, J., C. Drake, N. Leon, T. Mueller, and T. Troutt. 2000. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study. J. Clin. Microbiol. 38:2824-2828.
2. Chernesky, M. A., D. Jang, J. Sellors, K. Luinstra, S. Chong, S. Castriciano, and J. B. Mahony. 1997. Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women. Mol. Cell. Probes 11:243-249.
3. Ginocchio, C. C. 2007. Detection of respiratory viruses using non-molecular based methods. J. Clin. Virol. 40(Suppl. 1):S11-S14.
4. Krunic, N., T. D. Yager, D. Himsworth, F. Merante, S. Yaghoubian, and R. Janeczko. 2007. xTAG RVP assay: analytical and clinical performance. J. Clin. Virol. 40(Suppl.):S39-S46.
5. Liao, R. S., L. L. Tomalty, A. Majury, and D. E. Zoutman. 2009. Comparison of viral isolation and multiplex real-time reverse transcription-PCR for confirmation of respiratory syncytial virus and influenza virus detection by antigen immunoassays. J. Clin. Microbiol. 47:527-532.
6. Mahony, J., S. Chong, F. Merante, S. Yaghoubian, T. Sinha, C. Lisle, and R. Janeczko. 2007. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J. Clin. Microbiol. 45:2965-2970.
7. Mahony, J., S. Chong, M. Smieja, A. Petrich, S. Buracond, and J. Babwah. 2007. Establishing the epidemiology of respiratory virus infections using molecular technology, abstr. C-070. Abstr. 107th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
8. Mahony, J. B. 2008. Detection of respiratory viruses by molecular methods Clin. Microbiol. Rev. 21:716-747.
9. Mahony, J. B., and S. Chong. 2007. Clinical evaluation of the xTAGTM RVP assay for respiratory viruses, abstr. O-348. Abstr. Annu. Meet. of CACMID/AMMI.
10. Mahony J. B., S. Chong, M. Smieja, A. Petrich, S. Buracond, and J. Babwah. 2008. Abstr. 18th Annu. Meet. ECCMID, abstr. P1605.
11. Ontario Case Costing Initiative and the Ontario Case Cost Project. 2006. Ontario Case Cost Program Database. 1995-1996 Ontario guide to case costing. Ontario Ministry of Health and Long-Term Care, Toronto, Ontario, Canada. Accessed March 5 2009.
12. Ontario Ministry of Health and Long-Term Care. 2007. e-Formulary. Ontario drug benefit formulary/comparative drug index: electronic version, version 1.4. Queen's Printer for Ontario, Toronto, Ontario, Canada. https://www.healthinfo. moh.gov.on.ca/formulary/index.jsp.
13. Oosterheert, J. J., A. M. van Loon, R. Schuurman, A. I. M. Hoepelman, E. Hak, S. Thijsen, G. Nossent, M. M. E. Schneider, W. M. N. Hustinx, and M. J. M. Bonten. 2005. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin. Infect. Dis. 41:1438-1444.
14. Pabbaraju, K., K. L. Tokaruk, S. Wong, and J. D. Fox. 2008. Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections. J. Clin. Microbiol. 46:3056-3062.
15. Smit, M., K. A. Beynon, D. R. Murdoch, and L. C. Jennings. 2007. Comparison of the NOW Influenza A & B, NOW Flu A, NOW Flu B, and Directigen Flu A+B assays, and immunofluorescence with viral culture for the detection of influenza A and B viruses. Diagn. Microbiol. Infect. Dis. 57:67-70.
16. U.S. FDA. 2008. U.S. FDA review, decision summary, database updated 6 March 2008, p. 1-39. U.S. FDA, Washington, DC. www.accessdata.fda.gov.scripts. cdrh/.
17. Woo, P. C., S. S. Chiu, W.-E. Seto, and M. Peiris. 1997. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients. J. Clin. Microbiol. 35:1579-1581.